List view / Grid view
Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan (CT), more accurately than current methods.
Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth...
The mismatch between two MRI methods could signify early stroke status, allowing the use of 'clot-busting' drug...
Life-saving opioid overdose drug may benefit stroke patients...
An anti-inflammatory drug given to patients in the early stages of a stroke has been shown to reduce harmful inflammation...
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light...
11 May 2017 | By Sarah Wills, Editorial Assistant
An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.
8 February 2017 | By Niamh Marriott, Digital Editor
Keele University stroke specialist Professor Christine Roffe is leading ground breaking clinical trials into a smart chip that could save lives.
30 November 2016 | By
A team of scientists found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting...
4 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The PISCES I study was the first clinical trial of ReNeuron’s CTX cell therapy candidate for patients with motor disability as a consequence of ischaemic stroke. The data, collated over two years relates to the eleven stroke patients treated in the study...
2 August 2016 | By GlobalData
The atrial fibrillation market will expand from approximately $8 billion in 2015 to hit its peak of $11.8 billion in 2022, after which the impact of patent expiries will see the market value fall rapidly to $4.9 billion by 2025, according to research and consulting firm GlobalData...
27 June 2016 | By Victoria White, Digital Content Producer
Edoxaban is an oral anticoagulant that specifically inhibits factor Xa, which is an important factor in the coagulation system that leads to blood clotting...
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have shown a modified dosage rtPA can reduce serious bleeding in the brain and improve survival rates in patients with acute stroke...
23 March 2016 | By Victoria White
The SOCRATES trial evaluated Brilinta (ticagrelor) versus aspirin for the prevention of major vascular events in patients with an acute ischaemic stroke...
13 October 2015 | By Daiichi Sankyo
Daiichi Sankyo has teamed up with World Thrombosis Day to promote awareness of thrombosis, its causes, risk factors, and signs and symptoms...
